InflaRx Reports First Quarter 2021 Financial & Operating Results

NEXT STORY
Sensei Biotherapeutics Reports First Quarter 2021 Results and Provides Business Update
PREV STORY
Trevena Announces Presentation of OLINVYK® Respiratory Safety Data in High-Risk Patients at the 46th Annual ASRA Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

The dilutions segment held the largest share of the market in 2020, whereas the ointments segment is anticipated to register the highest CAGR during 2021–2028

author_avatar
NASDAQ Market News

Intellia and Regeneron Announce Landmark Clinical Data Showing Deep Reduction in Disease-Causing Protein After Single Infusion of NTLA-2001, an Investigational CRISPR Therapy for Transthyretin (ATTR) Amyloidosis

author_avatar
NASDAQ Market News

HOOKIPA Announces Changes to its Board of Directors – Resignation of Sander van Deventer

author_avatar
NASDAQ Market News